Mental health in HIV seronegative and seropositive IDUs in South Florida

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 2, 2010, Pages 152-158

  Jones, Deborah L ^a   Waldrop Valverde, Drenna ^a   Gonzalez, Peggy ^a   MacK, Alison ^a   Kumar, Adarsh M ^a   Ownby, Ray ^b   Weiss, Stephen M ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

HIV; IDU; Mental health; Prevention; Urban

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; SEROLOGY; UNITED STATES;

ADULT; AGED; ANXIETY; DEPRESSION; DRUG USERS; FATIGUE; FEMALE; FLORIDA; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PHYSICAL FITNESS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 77949590688     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903039851     Document Type: Article

References (34)

1. Barash, E.T., Hanson, D.L., Buskin, S.E., & Teshale, E. (2007). HIV-infected injection drug users: Health care utilization and morbidity. Journal of Health Care for the Poor and Underserved, 3, 675-686.
2. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychology, 4, 53-63.
3. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728.
4. Broman, C.L., Neighbors, H.W., Delva, J., Torres, M., & Jackson, J.S. (2008). Prevalence of substance use disorders among African Americans and Caribbean Blacks in the national survey of American life. American Journal of Public Health, 98(6), 1107-1114.
5. Centers for Disease Control (CDC). (2003). Division of HIV/AIDS prevention: Fact sheets. Retrieved September 12, 2008, from http://www.cdc.gov/ hiv/pubs/ facts.htm
6. Centers for Disease Control and Prevention (CDC). (2001). Youth risk behavior surveillance system. Retrieved September 12, 2008, from http://apps.nccd.cdc.gov/ YRBSS/index.asp
7. Chitwood, D.D., Sanchez, J., Comerford, M., Page, J.B., McBride, D.C., & Kitner, K.R. (2000). First injection and current risk factors for HIV among new and longterm injection drug users. AIDS Care, 12, 313-320.
8. Cook, J.A., Grey, D.D., Burke-Miller, J.K., Cohen, M.H., Vlahov, D., Kapadia, F., et al. (2007). Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Dependence, 89(1), 74-81. (Epub February 8, 2007).
9. Dallman, M.F., Pecoraro, N., Akana, S.F., La Fleur, S.E., Gomez, F., Houshyar, H., et al. (2003). Chronic stress and obesity: A new view of comfort food. Proceedings of the National Academy of Sciences of the United States of America, 100(20), 11696-11701.
10. Des Jarlais, D.C., Dehne, K., & Casabona, J. (2001). HIV surveillance among injecting drug users. AIDS, 15(Suppl. 3), S13-S22.
11. Dinwiddie, S.H., Reich, T., & Cloninger, R.C. (1992). Psychiatric comorbidity and suicidality among intravenous drug users. Journal of Clinical Psychiatry, 53, 364-369.
12. Estrada, A.L. (2005). Health disparities among African- American and Hispanic drug injectors- HIV, AIDS, hepatitis B virus and hepatitis C virus: A review. AIDS, 19(Suppl. 3), S47-S52.
13. Florida Department of Health. (2007, July). National HIV behavioural surveillance: IDU cycle preliminary findings. FL: Bureau of AIDS.
14. Georgiou, M.F., Gonenc, A., Waldrop-Valverde, D., Kuker, R.A., Ezuddin, S.H., Sfakianakis, G.N., et al. (2008). Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. Journal of Nuclear Medicine, 49, 1999-2005.
15. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
16. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-61.
17. Ickovics, J.R., Hamburger, M.E., Vlahov, D., Schoenbaum, E.E., Schuman, P., Boland, R.J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study. JAMA, 285(11), 1466-1474.
18. Institute of Medicine (IOM). (2004). Health literacy: A prescription to end confusion. In L. Nielsen-Bohlman, A. Panzer, & D.A. Kindig (Eds.), Washington, DC: National Academy Press.
19. Jackson, C.T., Covell, N.H., Drake, R.E., & Essock, S.M. (2007). Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders. Psychiatric Services, 58(2), 270-272.
20. Jackson, J. (2008, August 30). Keynote address. 10th international congress of behavioral medicine, Tokyo.
21. Joseph, J., Stoff, D.M., & van der Horst, C. (2005). HIV/ hepatitis C virus co-infection: Basic, behavioral and clinical research in mental health and drug abuse. AIDS, 19(Suppl. 3), S3-S7.
22. Kutner, M., Greenberg, E., & Baer, J. (2005). A first look at the literacy of America's adults in the 21st century (National Center for Education Statistics Publication No. 2006-470). Washington, DC: National Center for Education Statistics, US Department of Education.
23. Lansky, A., Abdul-Quader, A.S., Cribbin, M., Hall, T., Finlayson, T.J., Garfein, R.S., et al. (2007). Developing an HIV behavioral surveillance system for injecting drug users: The national HIV behavioral surveillance system. Public Health Reports, 122(Suppl. 1), 48-55.
24. Latkin, C.A., Buchanan, A.S., Metsch, L.R., Knight, K., Latka, M.H., Mizuno, Y., et al., the Intervention for Seropositive Injectors-Research Evaluation Team. (2008). Predictors of sharing injection equipment by HIV-seropositive injection drug users. JAIDS, 49, 447-450.
25. Lieb, S., Friedman, S.R., Zeni, M.B., Chitwood, D.D., Liberti, T.M., Gates, G.J., et al. (2004). An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(3), 15-28.
26. McNair, M., Lorr, M., & Droppleman, L. (1992). Manual of the profile of mood states. San Diego, CA: EdITS Educational and Industrial Testing Service.
27. Mehtaa, S.H., Thomas, D.L., Sulkowski, M.S., Safaeina, M., Vlahov, D., & Strathdeea, S.A. (2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-coinfected injection drug users. AIDS, 19(Suppl. 3), S179-S189.
28. Shear, M.K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M.W., et al. (2001). Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depression and Anxiety, 43, 22-46.
29. Sulkowski, M.S., & Thomas, D.L. (2005). Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness. AIDS, 19(Suppl. 3), S8-S12.
30. Valverde, E.E., Purcell, D.W., Waldrop-Valverde, D., Malow, R., Knowlton, A.R., Gó mez, C.A., et al., for the INSPIRE Study Team. (2007). Correlates of depression among HIV-positive women and men who inject drugs. Journal of Acquired Immune Deficiency Syndromes, 46(S21), S96-S100.
31. Waldrop, D., Ownby, R.L., & Kumar, M. (2004). Serial position effects in HIV-infected injecting drug users. International Journal of Neuroscience, 114, 493-516.
32. Waldrop-Valverde, D., Ownby, R.L., & Kumar, M. (2005). Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users. Psychiatry and Clinical Neurosciences, 59, 372-378.
33. Williams, J.B.W. (1988). The structured interview guide for the Hamilton Anxiety and Depression Rating Scales (SIGH-AD). New York, NY: Biometrics Research Unit, New York State Psychiatric Institute.
34. Williams, J.B.W. (1996). Structured interview guide for the Hamilton Depression and Anxiety Scales (SIGH-AD). New York, NY: New York State Psychiatric Institute.